Insider trading

Period: 120 months Stock: ARDX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

346 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

346 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

346 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

346 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
346 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
346 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

346 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
28 Jun 2024
RAAB MICHAEL President & CEO
Sold on a plan
$15.22K 2,310 at 6.59
0.2%
Planned (10b5-1)
21 Jun 2024
Blanks Robert See Remarks
Sold on a plan
$226.29K 38,000 at 5.96
10.5%
Planned (10b5-1)
13 Jun 2024
RAAB MICHAEL President & CEO
Sold on a plan
$232.74K 35,000 at 6.65
2.7%
Planned (10b5-1)
5 Jun 2024
Williams Laura A Chief Medical Officer
Sold at will 2×
$1.03M 145,000 at 7.12
31.0%
Not planned
3 Jun 2024
Rosenbaum David P. Chief Development Officer · indirect
Sold at will
$125.10K 17,872 at 7.00
10.1%
Not planned
29 May 2024
RAAB MICHAEL President & CEO
Sold on a plan
$50.39K 7,500 at 6.72
0.6%
Planned (10b5-1)
21 May 2024
RAAB MICHAEL President & CEO
Sold at will
$245.92K 31,484 at 7.81
2.4%
Not planned
21 May 2024
GRAMMER ELIZABETH A See Remarks
Sold at will
$54.11K 6,927 at 7.81
3.4%
Not planned
21 May 2024
Rodriguez Susan Chief Commercial Officer
Sold at will
$52.36K 6,703 at 7.81
1.5%
Not planned
21 May 2024
Renz Justin A Chief Financial Officer
Sold at will
$40.36K 5,167 at 7.81
1.7%
Not planned
21 May 2024
Blanks Robert See Remarks
Sold at will
$37.92K 4,855 at 7.81
1.3%
Not planned
21 May 2024
Rosenbaum David P. Chief Development Officer
Sold at will
$37.92K 4,855 at 7.81
1.3%
Not planned
21 May 2024
Williams Laura A Chief Medical Officer
Sold at will
$37.45K 4,794 at 7.81
1.3%
Not planned
21 May 2024
Felsch Robert Ora See Remarks
Sold at will
$27.22K 3,485 at 7.81
3.5%
Not planned
21 May 2024
Rosenbaum David P. Chief Development Officer · indirect
Sold at will
$17.17K 2,198 at 7.81
1.2%
Not planned
14 May 2024
RAAB MICHAEL President & CEO
Sold on a plan
$23.97K 3,000 at 7.99
0.2%
Planned (10b5-1)
6 May 2024
GRAMMER ELIZABETH A See Remarks
Sold at will 2×
$2.52M 284,170 at 8.88
58.2%
Sold half or more
6 May 2024
Felsch Robert Ora See Remarks
Sold at will 2×
$1.83M 207,988 at 8.81
68.4%
Sold half or more
3 May 2024
GRAMMER ELIZABETH A See Remarks
Sold on a plan
$405.00K 45,000 at 9.00
14.4%
Planned (10b5-1)
3 May 2024
Williams Laura A Chief Medical Officer
Sold on a plan
$333.57K 39,949 at 8.35
9.7%
Planned (10b5-1)
29 Apr 2024
RAAB MICHAEL President & CEO
Sold on a plan
$192.06K 30,000 at 6.40
2.2%
Planned (10b5-1)
15 Apr 2024
RAAB MICHAEL President & CEO
Sold on a plan
$52.92K 7,500 at 7.06
0.6%
Planned (10b5-1)
1 Apr 2024
RAAB MICHAEL President & CEO
Sold on a plan
$11.10K 1,518 at 7.31
0.1%
Planned (10b5-1)
20 Mar 2024
GRAMMER ELIZABETH A See Remarks
Sold on a plan
$664.98K 86,000 at 7.73
21.6%
Planned (10b5-1)
26 Feb 2024
Rosenbaum David P. Chief Development Officer · indirect
Sold at will
$47.68K 5,183 at 9.20
2.9%
Not planned
20 Feb 2024
RAAB MICHAEL President & CEO
Sold at will
$200.44K 22,917 at 8.75
1.7%
Not planned
20 Feb 2024
Rodriguez Susan Chief Commercial Officer
Sold at will
$60.59K 6,928 at 8.75
1.5%
Not planned
20 Feb 2024
Renz Justin A Chief Financial Officer
Sold at will
$46.71K 5,341 at 8.75
1.7%
Not planned
20 Feb 2024
Blanks Robert See Remarks
Sold at will
$43.88K 5,017 at 8.75
1.3%
Not planned
20 Feb 2024
Rosenbaum David P. Chief Development Officer
Sold at will
$43.88K 5,017 at 8.75
1.3%
Not planned
20 Feb 2024
Williams Laura A Chief Medical Officer
Sold at will
$42.01K 4,803 at 8.75
1.2%
Not planned
20 Feb 2024
GRAMMER ELIZABETH A See Remarks
Sold at will
$38.76K 4,432 at 8.75
1.1%
Not planned
20 Feb 2024
Felsch Robert Ora See Remarks
Sold at will
$20.57K 2,352 at 8.75
1.3%
Not planned
20 Feb 2024
Rosenbaum David P. Chief Development Officer · indirect
Sold at will
$20.06K 2,294 at 8.75
1.3%
Not planned
8 Feb 2024
Rosenbaum David P. Chief Development Officer
Sold on a plan
$140.85K 15,344 at 9.18
3.8%
Planned (10b5-1)
8 Jan 2024
Rosenbaum David P. Chief Development Officer
Sold on a plan
$199.20K 30,000 at 6.64
9.5%
Planned (10b5-1)
26 Dec 2023
Renz Justin A Chief Financial Officer
Sold on a plan
$1.43M 225,000 at 6.36
55.2%
Sold half or more
18 Dec 2023
Rosenbaum David P. Chief Development Officer
Sold on a plan
$34.45K 5,675 at 6.07
1.8%
Planned (10b5-1)
14 Dec 2023
Rosenbaum David P. Chief Development Officer
Sold on a plan
$38.85K 7,000 at 5.55
2.1%
Planned (10b5-1)
11 Dec 2023
GRAMMER ELIZABETH A See Remarks
Sold on a plan
$253.93K 50,000 at 5.08
15.4%
Planned (10b5-1)
8 Dec 2023
Rosenbaum David P. Chief Development Officer
Sold on a plan
$105.48K 20,000 at 5.27
5.7%
Planned (10b5-1)
5 Dec 2023
Rosenbaum David P. Chief Development Officer
Sold on a plan
$51.36K 10,272 at 5.00
2.9%
Planned (10b5-1)
30 Nov 2023
Rosenbaum David P. Chief Development Officer
Sold on a plan
$13.50K 3,000 at 4.50
0.8%
Planned (10b5-1)
20 Nov 2023
RAAB MICHAEL President & CEO
Sold at will
$49.59K 11,368 at 4.36
1.3%
Not planned
20 Nov 2023
Rodriguez Susan Chief Commercial Officer
Sold at will
$20.56K 4,714 at 4.36
1.3%
Not planned
20 Nov 2023
Renz Justin A Chief Financial Officer
Sold at will
$12.53K 2,873 at 4.36
0.9%
Not planned
20 Nov 2023
Blanks Robert See Remarks
Sold at will
$12.37K 2,835 at 4.36
1.1%
Not planned
20 Nov 2023
Rosenbaum David P. Chief Development Officer
Sold at will
$12.37K 2,835 at 4.36
0.8%
Not planned
20 Nov 2023
Williams Laura A Chief Medical Officer
Sold at will
$11.26K 2,581 at 4.36
1.0%
Not planned
20 Nov 2023
GRAMMER ELIZABETH A See Remarks
Sold at will
$10.40K 2,384 at 4.36
0.7%
Not planned
Showing 101–150 of 346. ← Newer Page 3 of 7 Older →